Blood test could spot cartilage cancer early
NCT ID NCT07492823
First seen Apr 06, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This study looks at whether a blood test (liquid biopsy) can help diagnose and monitor cartilage tumors called chondrosarcomas. Researchers will collect blood samples from 60 patients over two years to look for specific genetic changes linked to these tumors. The goal is to see if this non-invasive method can replace or reduce the need for repeated imaging and tissue biopsies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA OF THE BONE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Orthopaedics and Trauma
Graz, Styria, 8036, Austria
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.